Laura Naert

The prevalence and clinical significance of 68Ga-DOTANOC incidentaloma

Laura Naert, Sigrid G. Stroobants, Timon Vandamme, Christophe E.M. De Block et autres

With increased use of somatostatin analogue (SSA) PET/CT, the prevalence of incidentaloma - at present approximately 4.5% - is anticipated to rise. As malignancy has been reported in 13% of all cases, these incidentaloma are clinically relevant. However, because of publication bias, …

be (code pays fourni par la source)

SUN-298 Ga-68 DOTANOC incidentaloma; a higher prevalence but lower rate of malignancy than expected

Carlien De Herdt, Laura Naert, Sigrid G. Stroobants, Christophe E.M. De Block

Abstract Disclosure: C. De Herdt: None. L. Naert: None. S. Stroobants: None. C. De Block: None. Introduction: Ga-68 DOTANOC PET/CT is increasingly performed, which may lead to an increase of incidentaloma. In 2022, Bentestuen et al. published a systematic review concerning Ga-68 …

be (code pays fourni par la source)

The efficacy and safety of switching from rapid acting insulins to ultra rapid insulin l ispro (URLi) in people with type 1 diabetes using continuous glucose monitoring: a real world study

Laura Naert, Peter Coremans, Sabien Driessens, den van et autres